Share
Champions of Science

Behind the Revolution in Cancer Therapy

Share
Immunologist James Allison has spent over 30 years studying T cells and developing strategies for cancer immunotherapy. Now, he’s looking at new ways to unleash the immune system to eradicate cancer.

When James Allison started researching T cells in the 1980s, he didn’t intend to cure cancer. He was just interested in the immune system. More than 30 years later, his work forms the basis for many of the most promising cancer therapeutics available today. Allison is now the chief immunologist at the University of Texas MD Anderson Cancer Center and the winner of the 2018 Dr. Paul Janssen Award but he still remembers his roots in research. And he’s reaching back to them to drive his immunology revolution forward once again.

This video was produced for Johnson & Johnson Innovation by Scientific American Custom Media, a division separate from the magazine's board of editors

Champions of Science is a multifaceted initiative to convene and catalyze champions of science, and engage people of all generations and backgrounds to see the unlimited opportunities that science brings.

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue